Abstract:ObjectiveTo evaluate whether curettage with adjuvant microwave therapy was successful in the treatment of giant cell tumor of the bone (GCTB) in extremities, especially for GCTB with pathological fractures and GCTB of the distal radius. MethodsThis was a retrospective study of 54 cases of GCTB of the extremities treated by curettage with adjuvant microwave therapy between 2007 and 2019. Five patients were lost to follow up and excluded from the study. A total of 33 male and 21 female patients were included in this study. Patients were aged 15–57 years (mean 29.72 ± 10.48 years). Among these patients, there were 10 cases of GCTB with pathological fractures and eight cases of GCTB of the distal radius; one of these cases was combined with a pathological fracture. Comprehensive imaging examinations (X‐rays [including lesion site and chest], CT, MRI, emission computed tomography, and pathology examination) of all patients were reviewed. The clinical staging of these patients were evaluated radiologically using the Campanacci classification system based on the extent of spread of the tumor. All patients underwent curettage with adjuvant microwave therapy. Clinical and imaging evaluations were performed in all cases to check for recurrence or metastasis. Lower limb and upper limber function were assessed using the Musculoskeletal Tumor Society score (MSTS), and wrist function was assessed according to the disabilities of the arm, shoulder and hand (DASH) score. Data on surgical‐related complications were recorded. ResultsAll cases were followed up for 24–126 months (mean 60.69 ± 29.61 months). There were 24 patients with a Campanacci grade of 3 and 30 with a Campanacci grade of 2. The 52 patients were continuously disease‐free. The local recurrence rate was 3.70% (2 patients). One patient had recurrence in the proximal femur, and the other developed in soft tissue of the calf muscle. No recurrence occurred for GCTB of the distal radius. One recurrence occurred in a GCTB with pathological fractures. The intervals were 9 and 28 months, respectively. The cases of recurrence all had a Campanacci grade of 3 (8.33%). The median MSTS among the 54 patients was 27.67 ± 3.81. The mean wrist function DASH score was 8.30 ± 2.53. The mean MSTS was 28.67 ± 1.63 and 26.71 ± 5.49 for patients with GCTB of the distal radius and for those with pathological fractures, respectively. In comparing patients with and without pathological fractures, there was no significant difference in the MSTS functional score. Five patients had complications after the surgery. ConclusionCurettage with adjuvant microwave ablation therapy provided favorable local control and satisfactory functional outcomes in the treatment of GCTB, especially for cases with pathological fractures and those with GCTB of the distal radius.

Microwave in situ inactivation technique for the treatment of giant cell tumor of bone: a systematic review and meta-analysis

Microwave in situ inactivation in the treatment of bone giant cell tumor: a mid-term descriptive study

Novel Strategy of Curettage and Adjuvant Microwave Therapy for the Treatment of Giant Cell Tumor of Bone in Extremities: A Preliminary Study

Application of microwave ablation in the treatment of Campanacci grake Ⅲ giant cell tumor of bone of the limbs

Related Factors and Treating of Recurrent Giant Cell Tumor of Bone by Microwave Ablation Hyperthermia

Microwave Ablation of Primary Malignant Pelvic Bone Tumors

Combined preoperative denosumab and adjuvant microwave ablation for high-risk giant cell tumor of bone: a retrospective study in a single center

Treating Methods of Giant Cell Tumor of Long Bone: Microwave Hyperthermia and Self-ilium, Allogeneic Bone Particles and Bone Cement Repair

Use of Percutaneous Microwave Ablation for the Treatment of Bone Tumors: a Retrospective Study of Clinical Outcomes in 47 Patients.

Long-term Effects of Ultrasound-Guided Microwave Ablation in the Treatment of Small Renal Cell Carcinoma

Mechanism of Immunogenic Cell Death Induced by Microwave Ablation in Treatment of Osteosarcoma

Clinical Guideline for Microwave Ablation of Bone Tumors in Extremities

Immunomodulatory effects of microwave ablation on malignant tumors

Microwave Ablation of Malignant Extremity Bone Tumors

Percutaneous Microwave Ablation of Renal Cell Carcinoma: Practice Guidelines of the Ultrasound Committee of Chinese Medical Association, Interventional Oncology Committee of Chinese Research Hospital Association.

Clinical Study on the Efficacy of Microwave Ablation (MA) in the Treatment of Stage I Renal Clear Cell Carcinoma by CT and MRI Imaging

Microwave Ablation in Combination with Chemotherapy for the Treatment of Advanced Non-Small Cell Lung Cancer

Clinical Efficacy of Microwave Ablation Combined with Percutaneous Osteoplasty in the Treatment of Flat Bone Metastases

Therapeutic Effects of CT-guided Microwave Ablation Combined with Cementoplasty in the Treatment of Bone Metastasis

CT-guided Percutaneous Microwave Ablation of Pulmonary Malignancies: Results in 69 Cases

Salvaging the mandible invaded by the tumor with microwave hyperthermia